Treatment of non-cirrhotic, non-tumoural portal vein thrombosis

Mínguez, 2006, Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy, Hepatology, 43, 707, 10.1002/hep.21126 Turnes, 2008, Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. AGA Institute, Clin Gastroenterol Hepatol, 6, 1412, 10.1016/j.cgh.2008.07.031 DeLeve, 2009, Vascular disorders of the liver, Hepatology, 49, 1729, 10.1002/hep.22772 Amitrano, 2007, Prognostic factors in noncirrhotic patients with splanchnic vein thromboses, Am J Gastroenterol, 102, 2464, 10.1111/j.1572-0241.2007.01477.x Garcia-Pagan, 2008, Extrahepatic portal vein thrombosis, Semin Liver Dis, 28, 282, 10.1055/s-0028-1085096 Condat, 2001, Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy, Gastroenterology, 120, 490, 10.1053/gast.2001.21209 Spaander, 2013, Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding, J Thromb Haemost, 11, 452, 10.1111/jth.12121 Rajani, 2010, The epidemiology and clinical features of portal vein thrombosis: a multicentre study, Aliment Pharmacol Ther, 32, 1154, 10.1111/j.1365-2036.2010.04454.x Plessier, 2010, Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study, Hepatology, 51, 210, 10.1002/hep.23259 Orr, 2007, Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up, Clin Gastroenterol Hepatol, 5, 80, 10.1016/j.cgh.2006.09.030 Dhiman, 2014, Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian National Association for Study of the Liver, J Clin Exp Hepatol, 4, S2, 10.1016/j.jceh.2014.02.003 De Gaetano, 1995, Cavernous transformation of the portal vein: patterns of lntrahepatic and splanchnic collateral circulation detected with Doppler sonography, AJR, 165, 1151, 10.2214/ajr.165.5.7572494 Condat, 2000, Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy, Hepatology, 32, 466, 10.1053/jhep.2000.16597 Llop, 2011, Portal cholangiopathy: radiological classification and natural history, Gut, 60, 853, 10.1136/gut.2010.230201 Chandra, 2001, Portal biliopathy, J Gastroenterol Hepatol, 16, 1086, 10.1046/j.1440-1746.2001.02562.x Condat, 2003, Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study, Hepatology, 37, 1302, 10.1053/jhep.2003.50232 Malkan, 1999, Cholangiopathy associated with portal hypertension: diagnostic evaluation and clinical implications, Gastrointest Endoscopy, 49, 344, 10.1016/S0016-5107(99)70011-8 Harmanci, 2007, Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes, World J Gastroenterol, 13, 2535, 10.3748/wjg.v13.i18.2535 Ohnishi, 1984, Formation of Hilar collaterals or cavernous transformation after portal vein obstruction by hepatocellular carcinoma, Gastroenterology, 87, 1150, 10.1016/S0016-5085(84)80077-3 Duseja, 2014, Portal cavernoma cholangiopathy. Clinical characteristics, J Clin Exp Hepatol, 4, S34 De Franchis, 2010, Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension, J Hepatol, 53, 762, 10.1016/j.jhep.2010.06.004 De Franchis, 2015, Expanding consensus in portal hypertension, J Hepatol, 63, 743, 10.1016/j.jhep.2015.05.022 Sarin, 2002, Extrahepatic portal vein obstruction, Semin Liver Dis, 22, 43, 10.1055/s-2002-23206 Sarin, 2014, Non-cirrhotic portal hypertension, Clin Liv Dis, 18, 451, 10.1016/j.cld.2014.01.009 Harmanci, 2007, Clinical characteristics of idiopathic portal hypertension, World J Gastroenterol, 13, 1906, 10.3748/wjg.v13.i13.1906 Alvarez, 2015, Portal obstruction in children. I: Clinical investigation and hemorrhage risk, J Pediatr, 103, 696, 10.1016/S0022-3476(83)80460-0 Kumar, 2014, Natural history of portal cavernoma cholangiopathy, J Clin Exp Hepatol, 4, S62, 10.1016/j.jceh.2013.08.003 Berzigotti, 2014, Imaging in clinical decision-making for portal vein thrombosis, Nat Rev Gastroenterol Hepatol, 11, 308, 10.1038/nrgastro.2013.258 Ueno, 1997, Color Doppler ultrasonography in the diagnosis of cavernous transformation of the portal vein, Clin Ultrasound, 25, 227, 10.1002/(SICI)1097-0096(199706)25:5<227::AID-JCU2>3.0.CO;2-F Rangari, 2003, Hepatic dysfunction in patients with extrahepatic portal venous obstruction, Liver Int, 23, 434, 10.1111/j.1478-3231.2003.00879.x Lee, 2008, Portal vein thrombosis: CT features, Abdom Imaging, 33, 72, 10.1007/s00261-007-9200-x Spaander, 2010, Ascites in patients with noncirrhotic nonmalignant extrahepatic portal vein thrombosis, Aliment Pharmacol Ther, 32, 529, 10.1111/j.1365-2036.2010.04375.x Plessier, 2012, Management of hepatic vascular diseases, J Hepatol, 56, S25, 10.1016/S0168-8278(12)60004-X Vilgrain, 2006, Atrophy-hypertrophy complex in patients with cavernous transformation of the portal vein: CT Evaluation 1, Radiology, 241, 149, 10.1148/radiol.2411051102 Marin, 2011, Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history, Eur Radiol, 21, 2074, 10.1007/s00330-011-2161-z Kalra, 2014, Imaging of portal cavernoma cholangiopathy, J Clin Exp Hepatol, 4, S44, 10.1016/j.jceh.2013.07.004 Primignani, 2008, The role of thrombophilia in splanchnic vein thrombosis, Semin Liver Dis, 28, 293, 10.1055/s-0028-1085097 Bittencourt, 2011, Portal vein thrombosis and Budd-Chiari syndrome, Hematol Oncol Clin North Am, 25, 1049, 10.1016/j.hoc.2011.09.011 Chait, 2005, Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis, Br J Haematol, 129, 553, 10.1111/j.1365-2141.2005.05490.x Hernandez-Guerra, 2005, Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome, Hepatology, 43, 27, 10.1002/hep.20990 Kiladjian, 2008, The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases, Blood, 111, 4922, 10.1182/blood-2007-11-125328 Tefferi, 2007, Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel, Blood, 110, 1092, 10.1182/blood-2007-04-083501 Primignani, 2006, Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis, Hepatology, 44, 1528, 10.1002/hep.21435 Smalberg, 2012, Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis, Blood, 120, 4921, 10.1182/blood-2011-09-376517 Nangalia, 2013, Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2, N Engl J Med, 369, 2391, 10.1056/NEJMoa1312542 Klampfl, 2013, Somatic mutations of calreticulin in myeloproliferative neoplasms, N Engl J Med, 369, 2379, 10.1056/NEJMoa1311347 Turón, 2015, European association for the study of the liver, J Hepatol, 62, 72 Plompen, 2015, Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis, Haematologica, 100, e226, 10.3324/haematol.2014.120857 Perarnau, 2008, Hepatic vascular involvement related to pregnancy, oral contraceptives, and estrogen replacement therapy, Semin Liver Dis, 28, 315, 10.1055/s-0028-1085099 El-Karaksy, 2011, Splachnic vein thrombosis in the Mediterranean area in children, Mediterr J Hematol Infect Dis, 3, e2011027, 10.4084/mjhid.2011.027 Pinto, 2004, Portal vein thrombosis in children and adolescents: the low prevalence of hereditary thrombophilic disorders, J Pediatric Surg, 39, 1356, 10.1016/j.jpedsurg.2004.05.005 El-Karaksy, 2015, Extrahepatic portal vein obstruction in Egyptian children, J Pediatr Gastroenterol Nutr, 60, 105, 10.1097/MPG.0000000000000548 Yadav, 1993, Do umbilical vein catheterization and sepsis lead to portal vein thrombosis? A prospective, clinical and sonographic evaluation, J Pediatr Gastroenterol Nutr, 17, 392, 10.1097/00005176-199311000-00010 Hall, 2011, Management of acute non-cirrhotic and non-malignant portal vein thrombosis: a systematic review, World J Surg, 35, 2510, 10.1007/s00268-011-1198-0 Hall, 2013, Impact of anticoagulation on outcomes in acute non-cirrhotic and non-malignant portal vein thrombosis: a retrospective observational study, Hepatogastroenterology, 60, 232 Chawla, 2009, Review article: the modern management of portal vein thrombosis, Aliment Pharmacol Ther, 30, 881, 10.1111/j.1365-2036.2009.04116.x Kumar, 2015, Portal vein obstruction – epidemiology, pathogenesis, natural history, prognosis and treatment, Aliment Pharmacol Ther, 41, 276, 10.1111/apt.13019 Uflacker, 2003, Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis, Tech Vasc Interv Radiol, 6, 59, 10.1053/tvir.2003.36433 Lopera, 2002, Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis, J Vasc Surg, 36, 1058, 10.1067/mva.2002.127526 Smalberg, 2008, Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis, Thromb Haemost, 100, 1084, 10.1160/TH08-01-0015 Hollingshead, 2005, Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis, J Vasc Interv Radiol, 16, 651, 10.1097/01.RVI.0000156265.79960.86 Plessier, 2006, Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome, Hepatology, 44, 1308, 10.1002/hep.21354 Thatipelli, 2010, Survival and recurrence in patients with splanchnic vein thromboses, Clin Gastroenterol Hepatol, 8, 200, 10.1016/j.cgh.2009.09.019 Garcia-Tsao, 2007, Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis, Hepatology, 46, 922, 10.1002/hep.21907 Spaander, 2008, Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study, Gastrointest Endosc, 67, 821, 10.1016/j.gie.2007.08.023 Qi, 2011, Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients, Dig Dis Sci, 57, 1072, 10.1007/s10620-011-1975-5 Orloff, 2014, Unshuntable extrahepatic portal hypertension revisited: 43 years’ experience with radical esophagogastrectomy treatment of bleeding esophagogastric varices, Am J Surg, 207, 46, 10.1016/j.amjsurg.2013.06.001 Belli, 1985, Portal thrombosis in cirrhotics, Ann Surg, 203, 286, 10.1097/00000658-198603000-00012 Warren, 1988, Management of variceal bleeding in patients with non-cirrhotic portal vein thrombosis, Ann Surg, 207, 623, 10.1097/00000658-198805000-00017 Saraswat, 2014, Endoscopic management of portal cavernoma cholangiopathy: practice, principles and strategy, J Clin Exp Hepatol, 4, S67, 10.1016/j.jceh.2013.08.011 Varma, 2014, Surgical management of portal cavernoma cholangiopathy, J Clin Exp Hepatol, 4, S77, 10.1016/j.jceh.2013.07.005 Perlemuter, 1996, Biliary obstruction caused by portal cavernoma: a study of 8 cases, J Hepatol, 25, 58, 10.1016/S0168-8278(96)80328-X Chawla, 2015, Portal vein thrombosis, J Clin Exp Hepatol, 5, 22, 10.1016/j.jceh.2014.12.008 Denninger, 2000, Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors, Hepatology, 31, 587, 10.1002/hep.510310307 Bosch, 2012, Hipertensión portal: recomendaciones para su evaluación y tratamiento: documento de consenso auspiciado por la AEEH y el CIBERehd, Gastroenterol Hepatol, 35, 421, 10.1016/j.gastrohep.2012.02.009